Aarti Drugs Limited — Share Issue/Capital Change 2021

Mar 14, 2021

Ref: ADL/SE/2020-21 Date: 14.03.2021

To, Listing/ Compliance Department BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001 BSE CODE – 524348

To, Listing/ Compliance Department National Stock Exchange of India Limited, "Exchange Plaza", Plot No. C/1, G Block,Bandra - Kurla Complex, Bandra (E), Mumbai – 400051 NSE SYMBOL: AARTIDRUGS

Sub: Intimation of Loss of Share Certificates / Issue of Duplicate Share Certificates under Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015

Dear Sir/Madam,

Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), we hereby inform you that the Company has received information from Link Intime India Private Limited, Registrar & Share Transfer Agent of the Company for Loss of share certificates, details of which is as under –

Folio No.	Name of	Certificate	Distinctive No.		No. of
	Shareholder	No.	From	To	Shares
030866	RAJENDRA V PAWAR	85355	25986795	25987544	750

The public is hereby cautioned against dealing in any way with the share certificates mentioned above. The duplicate share certificates will be issued only after compliance of required formalities in this regard.

This is for your information and records.

Thanking you,

Yours faithfully, FOR AARTI DRUGS LIMITED

RUSHIKESH DEOLE COMPANY SECRETARY & COMPLIANCE OFFICER ICSI M.No.: A54527